ADMA Biologics, Inc. (NASDAQ:ADMA) Q1 2025 Earnings Call Transcript
Operator: Good afternoon and welcome to the ADMA Biologics First Quarter 2025 Financial Results and Business Update Conference Call on Monday, May 7, 2025.
Adma Biologics Inc. (ADMA)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Royce & Associates Chuck Royce | 697,001 | $13,828,500 | +66% | 0.15% |
| 2. | Navellier & Associates Louis Navellier | 170,830 | $4,050,379 | -5% | 0.56% |
| 3. | Neo Ivy Capital Renee Yao | 20,944 | $415,528 | -93% | 0.13% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.71 | 130,000 | 443,265 | 2023-08-30 | Filing | ||
| $3.90 | 25,000 | 277,401 | 2023-08-24 | Filing | ||
| $2.86 | 6,993 | 1,034,825 | 2022-12-09 | Filing | ||
| $2.86 | 14,982 | 1,143,426 | 2022-12-09 | Filing | ||
| $2.86 | 14,983 | 2,203,708 | 2022-12-09 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $21.46 | 6,000 | 2,055,850 | 2025-04-15 | Filing | ||
| $21.46 | 15,000 | 2,061,850 | 2025-04-15 | Filing | ||
| $18.92 | 6,000 | 2,061,850 | 2025-03-19 | Filing | ||
| $18.92 | 15,000 | 2,067,850 | 2025-03-19 | Filing | ||
| $21.15 | 15,000 | 199,433 | 2024-11-22 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 37,286,308 | $739,760,351 | 0.02% | |
| 2. | 3,551,813 | $70,467,970 | 0.85% | |
| 3. | 3,048,946 | $59,210,531 | 0.1% | |
| 4. | 1,468,609 | $29,137,212 | 0.01% | |
| 5. | 1,288,121 | $25,556,321 | 0.01% |
News See All
20 Takeover Rumors Hedge Funds Are Buying
Hedge funds tend to pile up on a stock that gains or is expected to gain positive attention in a market.
10 Best Multibagger Stocks to Buy According to Billionaires
US Trade tariffs have triggered heightened volatility and amplified the downdraft in the equity markets.
Louis Navellier's 10 New Stock Picks
Navellier & Associates is an independent money management firm founded in 1987 by renowned growth analyst Louis Navellier.
10 Jim Cramer Stocks to Watch This Month
"They wipe out these gains pretty easily, don't they? Just like that, the sellers take away months, if not years, of profits because they want to get ahead of a potential recession.
ADMA Biologics, Inc. (NASDAQ:ADMA) Q4 2024 Earnings Call Transcript
Operator: Good afternoon and welcome to the ADMA Biologics Fourth Quarter and Full Year 2024 Financial Results and Business Update Conference Call on Monday, March 3rd, 2025.
8 Stocks on Jim Cramer's Radar
Jim Cramer, host of Mad Money, recently discussed some of the significant challenges the alcohol industry is facing.
15 Best Growth Stocks to Buy for the Next 5 Years
Kevin Mahn, President & CIO at Hennion & Walsh Asset Management, recently appeared on CNBC on January 6 to discuss the current market momentum and emphasize the need for investors to be selective in 2025...
12 Best Growth Stocks Under $25 to Buy Now
Most experts agree that the AI wave is not over yet.
12 Best Multibagger Stocks to Buy Right Now
The US equities continued their upward movement in 2024 and fueled the S&P 500 to record highs.
Billionaire Hedge Funds
